Levetiracetam Effect in Demyelinating Ocular Flutter with Myoclonus: Neuro-Ophthalmology: Vol 30, No 4

Views

CrossRef citations to date

Altmetric

Abstract

A 29-year-old male developed ocular flutter and subtle extremity myoclonus related to demyelination. Ocular flutter and myoclonus were symptomatically amenable to treatment with levetiracetam. Discontinuation of levetiracetam was associated with recurrent flutter and myoclonus over a two-year period of follow-up. Levetiracetam may be an effective agent for the symptomatic control of ocular flutter.

KEYWORDS:

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Levetiracetam Effect in Demyelinating Ocular Flutter with Myoclonus

Information for

Open access

Opportunities

Help and information

Levetiracetam Effect in Demyelinating Ocular Flutter with Myoclonus

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature